Skip to content
stoqly

Ensign Group

ENSG Nasdaq Health Care Facilities Financials FY2016–FY2025

Ensign Group's revenue rose 18.7% to $5.1 billion in fiscal 2025. Its operating margin was 8.4%, about the same as 8.4% a year earlier. It paid out $34 million in dividends and buybacks. The diluted share count rose 1.1%.

Last close · Oct 23, 2026

$175.59

1.5%
Value it Compare
Revenue Total sales reported in the income statement.
$5.1B
18.7% vs prior year
Operating margin Operating income as a share of revenue.
8.4%
0.0 pts
Net income Profit after all expenses, interest and tax.
$344M
15.4%
Free cash flow Cash from operations minus capital spending.
—
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
19.7%
1.8 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$10.4B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
27.5x
On $6.38 EPS (TTM)

About these figures. From 2020 Ensign Group's filings label its purchases of property and equipment in their own way, which the SEC's structured data leaves out, so capital spending and free cash flow are blank from 2020.

What Ensign Group does

No business description yet.

Legal name
ENSIGN GROUP, INC
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001125376-26-000007
0001125376

Revenue and margins

Ensign Group had $5.1B of revenue in fiscal 2025, up 18.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 22.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Ensign Group returned $34.4M to shareholders in fiscal 2025. The diluted share count rose 1.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Ensign Group yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of $428M and divides by 58.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 27.5x · peers 24.4x · sector 28.4x.

Balance sheet

Cash, debt and the ratios that show how comfortably Ensign Group can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $276M$332M$527M$527M$572M
Debt incl. finance leases $160M$156M$152M$148M$144M
Net debt / EBITDA −0.4x−0.5x−1.1x−0.9x−0.8x
Debt / equity 0.2x0.1x0.1x0.1x0.1x
Interest coverage 38.0x33.2x31.6x43.2x53.2x
Current ratio 1.2x1.3x1.4x1.6x1.4x
Quick ratio 1.2x1.3x1.4x1.6x1.4x
Total assets $2.9B$3.5B$4.2B$4.7B$5.5B
Total liabilities $1.8B$2.2B$2.7B$2.8B$3.2B
Shareholders' equity $1.0B$1.2B$1.5B$1.8B$2.2B
Net debt (− = net cash) −$116M−$175M−$375M−$379M−$428M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.9M

6 insiders

Of sales under plans

100%

$0.9M

DateInsiderTradeSharesPriceValueFiling
Oct 16, 2026 Mark Vincent ParkinsonDirector Sold plan 100 $179.62 $0.0M Form 4
Jul 27, 2026 Ann Scott BlouinDirector Sold plan 375 $183.54 $0.1M Form 4
Jul 20, 2026 John O AgwunobiDirector Sold plan 392 $171.06 $0.1M Form 4
Jul 16, 2026 Mark Vincent ParkinsonDirector Sold plan 100 $168.12 $0.0M Form 4
Jun 2, 2026 Barry M SmithDirector Sold plan 700 $164.28 $0.1M Form 4
May 4, 2026 Barry M SmithDirector Sold plan 700 $182.21 $0.1M Form 4
Apr 20, 2026 John O AgwunobiDirector Sold plan 392 $199.97 $0.1M Form 4
Apr 16, 2026 Mark Vincent ParkinsonDirector Sold plan 100 $196.60 $0.0M Form 4
Apr 2, 2026 Barry M SmithDirector Sold plan 700 $196.65 $0.1M Form 4
Mar 2, 2026 Barry M SmithDirector Sold plan 700 $213.02 $0.1M Form 4
Feb 20, 2026 Pison Marivic UychiatDirector Sold plan 67 $204.92 $0.0M Form 4
Feb 19, 2026 Beverly B. WittekindVP and Chief Legal Officer Sold plan 500 $210.23 $0.1M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✓
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✓ ✓
Current ratio rose ✓ ✓ ✕
Share count didn't rise ✕ ✕ ✕
Gross margin rose ✕ ✕ ✕
Revenue rose relative to assets ✓ ✕ ✓
F-score 6 / 96 / 96 / 9
Accruals ratio −4.4%−1.1%−4.4%
Altman Z'' 2.382.782.75

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Ensign Group ENSG $10.4B 18.7% 8.4% — 19.7% 27.5x 6
Option Care Health OPCH $4.9B 13.0% 6.0% 3.8% 11.4% 24.4x 5 Compare →
Encompass Health EHC $12.4B 10.5% — 7.4% 15.8% 20.2x 8 Compare →
Acadia Healthcare ACHC $2.9B 5.0% — −13.3% −16.0% — 4 Compare →
Astrana Health ASTH $1.9B 56.4% 2.5% 3.3% 4.2% 45.1x 4 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.7B $1.6B $1.8B $2.0B $2.4B $2.6B $3.0B $3.7B $4.3B $5.1B
Gross profit $313M $285M $336M $416M $537M $608M $671M $788M $884M $1.0B
Operating income $91.8M $43.2M $84.9M $129M $223M $261M $297M $255M $358M $425M
Interest expense $7.1M $13.6M $15.2M $15.7M $9.4M $6.8M $8.9M $8.1M $8.3M $8.0M
Pretax income $85.8M $31.2M $71.7M $116M $218M $258M $289M $273M $386M $456M
Income tax $33.0M $14.2M $12.7M $24.0M $46.2M $60.3M $64.4M $62.9M $87.6M $111M
Net income $50.0M $40.5M $92.4M $111M $171M $195M $225M $209M $298M $344M
Diluted EPS $0.96 $0.77 $1.70 $1.97 $3.06 $3.42 $3.95 $3.65 $5.12 $5.84
Diluted shares 0.05B 0.05B 0.05B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B
Cash flow
Cash from operations $73.9M $79.5M $210M $192M $373M $276M $273M $377M $347M $564M
Capital expenditure $65.7M $54.1M $50.9M $71.5M — — — — — —
Free cash flow $8.2M $25.5M $159M $121M — — — — — —
Depreciation and amortization $38.7M $42.3M $44.9M $51.1M $54.6M $56.0M $62.4M $72.4M $84.1M $104M
Stock-based compensation $9.1M $7.8M $8.4M $11.3M $14.5M $18.7M $22.7M $30.8M $36.2M $48.3M
Acquisitions $64.3M $77.5M $0.0M $6.5M $0.0M $6.0M $16.4M $0.0M $157M $323M
Share buybacks $30.0M $7.3M $0.0M $6.4M $25.0M $10.1M $29.9M $0.0M $0.0M $20.0M
Dividends paid $8.2M $8.7M $9.4M $10.2M $10.8M $11.5M $12.2M $12.9M $13.7M $14.4M
Dividends and buybacks $38.2M $16.0M $9.4M $16.6M $35.8M $21.7M $42.1M $12.9M $13.7M $34.4M
Balance sheet
Cash and short-term investments $69.3M $55.4M $39.7M $76.9M $250M $276M $332M $527M $527M $572M
Total debt $284M $316M $246M $330M $118M $160M $156M $152M $148M $144M
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $334M $368M $348M $411M $583M $640M $781M $1.0B $1.2B $1.3B
Current liabilities $212M $226M $269M $343M $562M $523M $582M $735M $743M $894M
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Property and equipment, net $485M $537M $608M $768M $778M $888M $992M $1.1B $1.3B $1.7B
Total assets $1.0B $1.1B $1.2B $2.4B $2.5B $2.9B $3.5B $4.2B $4.7B $5.5B
Total liabilities $541M $602M $580M $1.7B $1.7B $1.8B $2.2B $2.7B $2.8B $3.2B
Shareholders' equity $456M $492M $591M $654M $818M $1.0B $1.2B $1.5B $1.8B $2.2B
Margins
Gross margin 18.9% 17.8% 19.2% 20.4% 22.4% 23.1% 22.2% 21.1% 20.7% 20.5%
Operating margin 5.6% 2.7% 4.8% 6.3% 9.3% 9.9% 9.8% 6.9% 8.4% 8.4%
EBITDA margin 7.9% 5.4% 7.4% 8.9% 11.6% 12.0% 11.9% 8.8% 10.4% 10.5%
Net margin 3.0% 2.5% 5.3% 5.4% 7.1% 7.4% 7.4% 5.6% 7.0% 6.8%
FCF margin 0.5% 1.6% 9.1% 5.9% — — — — — —
Returns
Return on capital 9.8% 3.3% 8.9% 11.9% 22.0% 25.1% 23.3% 17.9% 21.4% 19.7%
Return on capital employed 13.5% 5.2% 9.5% 8.8% 11.2% 12.1% 11.4% 8.1% 9.7% 10.0%
Return on equity 11.3% 8.5% 17.1% 17.8% 23.2% 21.2% 19.8% 15.3% 17.9% 16.9%
Return on assets 5.7% 3.9% 8.1% 6.2% 7.0% 7.2% 7.1% 5.5% 6.7% 6.8%
Growth
Revenue growth — −3.4% 9.8% 16.1% 18.0% 9.4% 15.2% 23.3% 14.2% 18.7%
Net income growth −9.8% −19.0% 128.2% 19.7% 54.2% 14.2% 15.4% −6.8% 42.3% 15.4%
EPS growth −9.4% −19.8% 120.8% 15.9% 55.3% 11.8% 15.5% −7.6% 40.3% 14.1%
FCF growth — 211.0% 526.0% −24.3% — — — — — —
Share count change −0.2% 1.3% 3.0% 2.9% −0.4% 2.0% −0.1% 0.8% 1.6% 1.1%
Financial health
Net debt / EBITDA 1.7x 3.1x 1.6x 1.4x −0.5x −0.4x −0.5x −1.1x −0.9x −0.8x
Debt / equity 0.6x 0.6x 0.4x 0.5x 0.1x 0.2x 0.1x 0.1x 0.1x 0.1x
Interest coverage 12.9x 3.2x 5.6x 8.3x 23.8x 38.0x 33.2x 31.6x 43.2x 53.2x
Current ratio 1.6x 1.6x 1.3x 1.2x 1.0x 1.2x 1.3x 1.4x 1.6x 1.4x
Quick ratio 1.6x 1.6x 1.3x 1.2x 1.0x 1.2x 1.3x 1.4x 1.6x 1.4x
Capital allocation
Capex / revenue 4.0% 3.4% 2.9% 3.5% — — — — — —
Stock comp / revenue 0.6% 0.5% 0.5% 0.6% 0.6% 0.7% 0.8% 0.8% 0.9% 1.0%
Payouts / FCF 466.2% 62.9% 5.9% 13.8% — — — — — —
Quality scores
Piotroski F-score — 5.0 6.0 7.0 6.0 7.0 8.0 6.0 6.0 6.0
Altman Z'' 3.1 2.8 3.0 1.5 1.9 2.3 2.4 2.4 2.8 2.8
Accruals ratio −2.7% −3.7% −10.3% −4.6% −8.3% −3.0% −1.5% −4.4% −1.1% −4.4%

Source: SEC EDGAR XBRL filings (CIK 0001125376). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open